Seattle

Home/Tag: Seattle

The Stash, Volume 46: Market Share gains, profitability make Trulieve a standout cannabis name

MARKET SHARE GAINS, PROFITABILITY MAKE TRULIEVE A STANDOUT CANNABIS NAME Trulieve’s (TCNNF) continued market share gains validate our thesis that capital-efficient state leaders are best placed to emerge as winners in the U.S. cannabis market. Our analysis of data from the Florida Office of Medical Marijuana Use suggests that Trulieve’s dominance of Florida’s cannabis market continues [...]

2020-07-15T19:11:03+00:00June 3rd, 2020|

The Stash, Volume 45: Aurora Cannabis is up 176% in two weeks; will the rally sustain?

AURORA CANNABIS (ACB) IS UP 176% IN TWO WEEKS; WILL THE RALLY SUSTAIN? The acquisition of U.S. hemp retailer Reliva LLC gives Aurora Cannabis (ACB) a foothold into the $24 billion U.S. CBD market and is one of the key catalysts of the sharp appreciation in ACB’s stock price over the last couple of weeks. On [...]

2020-07-15T19:11:33+00:00May 27th, 2020|

The Stash, Volume 43: Cannabis 2.0 is here and COVID-19 is accelerating the transition

CANNABIS 2.0 IS HERE AND COVID-19 IS ACCELERATING THE TRANSITION Market share gains for marijuana products like edibles and vapor pens in Canada suggest that the transition from Cannabis 1.0 to Cannabis 2.0 is happening at a rapid pace, with stay-at-home restrictions imposed due to COVID-19 acting as an additional catalyst. The launch of cannabis products [...]

2020-07-15T19:12:30+00:00May 13th, 2020|

The Stash, Volume 39: COVID-19 is a Net Positive for Cannabis. Here’s why.

COVID-19 IS A NET POSITIVE FOR CANNABIS. HERE’S WHY. COVID-19’s impact on the cannabis industry is more positive than negative. While COVID-19 is a net negative for most industries, cannabis is among those where the net impact is positive. There are three reasons that bring us to this conclusion: 1) emergence of cannabis as an essential/staple, [...]

2020-04-15T19:48:06+00:00April 15th, 2020|

The Stash, Volume 38: Cannabis Legalization in 2020: A COVID-19 Casualty

CANNABIS LEGALIZATION IN 2020: A COVID-19 CASUALTY Cannabis legalization – key to the $50 billion+ illicit-to-legal value migration in the industry – is emerging as one of the casualties of the COVID-19 pandemic. In the last three weeks, we have discussed the impact that the spread of coronavirus is having on the cannabis industry, ranging from [...]

2020-04-08T15:44:35+00:00April 8th, 2020|

The Stash, Volume 37: Cannabis – The New Essential

CANNABIS: THE NEW ESSENTIAL Cannabis’ “essential” designation will drive sales higher even during the COVID-19 pandemic. We discussed in last week’s Stash report how cannabis sales saw a sharp surge in March as part of consumers’ stay-at-home strategy. These sales are likely to be boosted further by the classification of marijuana – especially medical marijuana – [...]

2020-04-01T16:44:50+00:00April 1st, 2020|

The Stash, Volume 35: Big Brands Key Contenders for the Billion-Dolllar CBD Beauty Opportunity

BIG BRANDS KEY CONTENDERS FOR THE BILLION-DOLLAR CBD BEAUTY OPPORTUNITY Driven by cannabidiol’s (CBD) wellness and cosmetic benefits, the U.S. CBD Beauty market is expected to grow to $1 billion+ in annual sales by 2025. Overall CBD sales in the U.S. are expected to grow from $1.8 billion in 2018 to $20 billion+ by 2024, according [...]

2020-03-30T13:50:43+00:00March 18th, 2020|

The Stash, Volume 31: The Valens Company – Extracting Value for Investors

THE VALENS COMPANY: EXTRACTING VALUE FOR INVESTORS The Valens Company (VLNCF) is one of the best cannabis extraction and testing names for investors to follow. Valens provides best-in-class proprietary services, including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, and white-label product development and manufacturing to leading Canadian and international cannabis brands. It has [...]

2020-03-30T14:00:46+00:00February 19th, 2020|

The Stash, Volume 29: Canna Finance – Set to Emerge from the Trough of Disillusionment?

CANNA FINANCE: SET TO EMERGE FROM THE TROUGH OF DISILLUSIONMENT? In our Dec. 18, 2019 Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. We expand on this subject this week by analyzing how cannabis companies went from being [...]

2020-03-30T14:02:42+00:00February 5th, 2020|
Go to Top